Amedisys Inc

Amedisys — Q1 2017 Earnings Presentation

17 slides from Amedisys's earnings presentation, May 2, 2017

  1. Slide 1: Amedisys First Quarter 2017 Earnings Call Supplemental Slides

    Amedisys First Quarter 2017 Earnings Call Supplemental Slides May 3, 2017 Exhibit 99.2

  2. Slide 2: Forward-looking statements

    This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cau

  3. Slide 3: What Investors Want

    What Investors Want Themes from the investor and analyst community that we will address and deliver on in 2017 Post 1Q’17, HCHB disruption should no longer impact operations HCHB 2.0 training will focus on optimization of the platform aimed at driving improved clinical outcomes and additional margin

  4. Slide 4: Highlights and Summary Financial Results (Adjusted): 1Q 2017

    Highlights and Summary Financial Results (Adjusted): 1Q 2017(1) Hospice and Personal Care continue their strong growth. Home Health total episodic admissions up 3% but Medicare FFS down 1%. Cost containment initiatives performing very well driving 1Q EBITDA Amedisys Consolidated Revenue Growth: +6%

  5. Slide 5: Home Health and Hospice Segment (Adjusted) – 1Q 2017

    Home Health and Hospice Segment (Adjusted) – 1Q 2017(1) Overall same store episodic admit growth was solid (+3%) driven by non-Medicare episodic admits (+35%); offset by decline in Medicare same store admissions (-1%) CPV increase anticipated due to planned salary increases and health care costs Hom

  6. Slide 6: General & Administrative Expenses – Adjusted

    General & Administrative Expenses – Adjusted (1,2) Notes: Year over year total G&A as a percentage of revenue decreased 270 basis points Home health segment G&A: 70 bps y/y decrease as % of revenue Hospice segment G&A: 210 bps decrease y/y as % of revenue Corporate G&A: 160 bps decrease y/y as % of

  7. Slide 7: How we're tracking

    How we’re tracking Clinical Distinction Employer of Choice Operational Excellence & Efficiency Driving Growth Outstanding Outcomes for Our Patients In Their Homes Care Centers & Clinical Teams Status Category Update Ongoing Initiative STARS / Quality Amedisys maintains a 4-Star average in the July 2

  8. Slide 8: Clinical Distinction: Improvements in STARS

    Clinical Distinction: Improvements in STARS 7th consecutive quarter of QPC STAR score improvement; 82% of providers at 4 stars or better Metric Jan 17 Release Apr 17 Release Jul 17 Preview Quality of Patient Care 3.91 4.03 4.13 Entities at 4+ Stars 65% 75% 82% Metric Oct 16 Release Jan 17 Release Ap

  9. Slide 9: Becoming Employer of Choice: Improving Return on Human Capital

    Becoming Employer of Choice: Improving Return on Human Capital Voluntary turnover company-wide has been trending down despite slight increase in Q1’17 Notes: Total voluntary turnover in 1Q’17 increased slightly: Customized voluntary turnover goals rolled out to each organization aimed at maintaining

  10. Slide 10: Operational Excellence: Roadmap to EBITDA Improvement

    Operational Excellence: Roadmap to EBITDA Improvement We continue to make progress towards our stated operational efficiencies ($46M annualized improvement vs. 2015 exit run rate) *Run Rate $46 million * Efficiencies and Disruption ($M) - 3 0 3 6 9 12 Q1'16 Q2'16 Q3'16 Q4'16 Q1'17 Q2'17 Q3'17 Q4'17

  11. Slide 11: Cost Per Visit Components

    $81.08 $79.14 Components 4Q’16 1Q’16 1Q’17 YoY Variance Detail Mitigation Plan Salaries $62.94 $60.48 $61.48 $1.00 $0.68 driven by planned salary increases $0.32 driven by utilization Initiatives in progress to drive down costs by labor mix optimization, productivity improvements and improved schedu

  12. Slide 12: Driving Top Line Growth: Metrics Across Business Segments

    Driving Top Line Growth: Metrics Across Business Segments Solid growth in hospice and personal care; Medicare revenue decrease due to reimbursement cut and significant growth in private episodic 234 Opportunities Prospected 45 Opportunities Under Review 13 Active Processes Personal Care Total Hours

  13. Slide 13: Driving Top Line Growth: Business Development Impact Analysis

    Driving Top Line Growth: Business Development Impact Analysis Unintended business development turnover has impacted overall growth in home health; however, productivity has increased. Hospice investment in business development has paid dividends Notes: The Home Health BD reorg (Project Redwood) impl

  14. Slide 14: Driving Top Line Growth: Hospice Success

    Driving Top Line Growth: Hospice Success In 2015, we made a concerted effort to improve our Hospice business unit. Since that time, Hospice has enjoyed eight consecutive quarters of top line growth, vast increases in ADC per care center and operating margin improvement via a disciplined approach to

  15. Slide 15: Debt and Liquidity Metrics

    Debt and Liquidity Metrics Low debt levels and strong cash flow have improved the flexibility of our balance sheet with ample available liquidity Net debt defined as total debt outstanding ($95M) less cash balance ($48M). Leverage ratio (net) is defined as net debt divided by last twelve months adju

  16. Slide 16: Adjusted EBITDA to Free Cash Flow Reconciliation

    Adjusted EBITDA to Free Cash Flow Reconciliation (1,2) Reduction in amount of non-GAAP adjustments result in adjusted EBITDA falling through to operating cash flow; looking return DSO to mid-30’s by YE’17. Capex target within projected goal for 2017 The financial results for the three-month periods

  17. Slide 17: Income Statement Adjustments

    Income Statement Adjustments (1) Amount of non-GAAP adjustments through 2016 have substantially decreased in 1Q’17 The financial results for the three-month periods ended March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, and March 31, 2017 are adjusted for certain items and shoul

Amedisys — Q1 2017 Earnings Presentation on 6ix